A213, a RORγt antagonist, improves Sjögren’s syndrome-like sialadenitis through downregulation of CD25

https://onlinelibrary.wiley.com/doi/abs/10.1111/odi.13255 https://www.ncbi.nlm.nih.gov/pubmed/31837283?dopt=Abstract TITLE: RORγt antagonist improves Sjögren’s syndrome-like sialadenitis through downregulation of CD25. DESCRIPTION: Related Articles RORγt antagonist improves Sjögren’s syndrome-like sialadenitis through downregulation of CD25. Oral Dis. 2020 May;26(4):766-777 Authors: Ono Y, Tsuboi H, Moriyama M, Asashima H, Kudo H, Takahashi H, Honda F, Abe S, Kondo Y, Takahashi S, Matsumoto I, Nakamura S, […]